Genitourinary Cancers Special Issue
Within the genitourinary cancer space, there have been many treatment advances over the past year.
As part of the “Speaking Out” series, a radiation oncologist discusses the benefits of MRI-guided stereotactic body radiation therapy.
Antibody-drug conjugates represent a paradigm shift for patients with cancer and providers.
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
3
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
4
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
5